Chunyan Wang
Tongji University
9 Papers
7 Citations
Chunyan Wang is an academic researcher from Tongji University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Uncommon EGFR mutations associate with lower incidence of T790M mutation after EGFR-TKI treatment in patients with advanced NSCLC
Shuo Yang,Shiqi Mao,Xuefei Li,Chao Zhao,Qian Liu,Xiaofei Yu,Yan Wang,Yiwei Liu,Yingying Pan,Chunyan Wang,Guanghui Gao,Wei Li,Anwen Xiong,Bin Chen,Hui Sun,Yayi He,Fengying Wu,Xiaoxia Chen,Chunxia Su,Shengxiang Ren,Caicun Zhou +20 more
TL;DR: Uncommon EGFR mutation showed a significantly lower incidence of acquired T790M mutation and benefited significantly less from subsequent osimertinib treatment than common EGFR mutations in patients with advanced NSCLC.
21
Performance of human papillomavirus E6/E7 mRNA assay for primary cervical cancer screening and triage: Population-based screening in China
TL;DR: The AHPV assay is both specific and sensitive for detecting HSIL+ and may be suitable for use in primary cervical cancer screening in China and a feasible triage strategy for women undergoing routine cervical screening.
9
Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung Cancer
Xiaofei Yu,Zhengwei Dong,Wanying Wang,Shiqi Mao,Yingying Pan,Yiwei Liu,Shuo Yang,Bin Chen,Chunyan Wang,Xuefei Li,Chao Zhao,Keyi Jia,Chuchu Shao,Chunyan Wu,Shengxiang Ren,Caicun Zhou +15 more
TL;DR: In this article, the authors investigated the association between an adnocarcinoma with high-grade patterns with the outcomes of first-line treatment in patients with lung cancer, and they reported that adenoccarinoma of high grade patterns had a significantly lower objective response rate (ORR; 15.6% vs 36.4%, P=0.045), shorter progression-free survival (PFS; median 4.1 vs 5.4 months, P= 0.007) and overall survival (OS, median 19.6 vs 23.8 months,
Inherited heterozygous Fanconi anemia gene mutations in a therapy-related CMML patient with a rare NUP98-HOXC11 fusion: A case report
Kefeng Shen,Meilan Zhang,Jiachen Wang,Wei Mu,Jin Wang,Chunyan Wang,Shu'Gang Xing,Zhenya Hong,Mingzhe Xiao +8 more
TL;DR: This patient developed ovarian cancer and secondary t-CMML and then suffered from BMF and delayed post−chemotherapy bone marrow recovery after several chemotherapy courses, which highlights the importance of genetic counseling in patients with hematopoietic neoplasms with high clinical suspicion for carrying cancer susceptibility gene mutations.
Serotype Features of 17 Suspected Cases of Foodborne Botulism in China 2019–2022 Revealed by a Multiplex Immuno-Endopep-MS Method
TL;DR: A feasible laboratorial method based on an isotope dilution Immuno-Endopep-MS to detect BoNTs and determine their serotypes and activities in clinical samples is developed, providing the first comprehensive analytical research on in vivo profiles of serotypes A, B, and E in different types of specimens from mixed botulism cases.